Ergebnis der Suchanfrage nach Switzerland
Inhalte
- Kategorie:
- Sprache:
- Medien:
- Zeitraum:
- Zeitraum:Gesamt
- mehr
Heidelberger Druckmaschinen AG
Gallus opens doors to new industry facility, celebrating 100th anniversary and unveiling new solutions to power a digital transformation
mehr- 2
IntercityHotel brand comes to Rotterdam-Schiedam
Ein Dokumentmehr Press Release: Instone Real Estate Group SE - AGM approves dividend distribution of EUR 0.35 per share; Sabine Georgi and Stefan Mohr new members of the Supervisory Board
Ein Dokumentmehr- 2
Hellmann expands product portfolio in Switzerland and opens Direct Load location in Kloten
mehr Studer Innotec, a premium Swiss manufacturer of battery-based solar inverters, will showcase its new "next3 rack" solution at Intersolar 2023 in Munich /"A Swiss Pocketknife for Energy": Studer's Next3 Rack Solution at Intersolar '23
mehrCIVIS Media Prize 2023 | eight programmes honoured and a special prize for Isabel Schayani
Berlin (ots) - The winners of the European CIVIS Media Prize for Integration and Cultural Diversity 2023 have been announced: The main prize of 15,000 euros, the CIVIS TOP AWARD, goes to the documentary ARTE THEMA: Last Refuge - The House at the Gate to the Sahara (ARTE G.E.I.E), by the author and director Ousmane Samassékou. A work about people on the move, on the ...
mehrOsmium-Institut zur Inverkehrbringung und Zertifizierung von Osmium GmbH
Osmium Fork Leads to Price Reduction and Free Compensation Deliveries
mehrCroma-Pharma: Launch of topical anaesthetic Pliaglis® in Europe
Vienna (ots/PRNewswire) - Croma-Pharma, a global player and challenger in the dynamically growing, minimally invasive aesthetics market, announces that it will launch Pliaglis®, a topical local anaesthetic for superficial dermatological procedures, in its European core markets including Germany, the United Kingdom ("UK"), and Ireland. Further markets including Brazil will follow by the end of 2023. The anaesthetic cream ...
mehrDEBIOPHARM LAUNCHES PHASE 1 RESEARCH IN SMALL CELL LUNG CANCER WITH WEE1 INHIBITOR DEBIO 0123 TO OUTSMART DDR IN SMALL CELL LUNG CANCER
Lausanne, Switzerland (ots) - - Debiopharm combines its potent WEE1-inhibitor Debio 0123 with standard-of-care therapy to short-circuit DNA damage repair (DDR) in adults with recurrent or progressive small cell lung cancer (SCLC). - The first patient dosed at Vall d’Hebron Hospital (Barcelona, Spain), was ...
mehrGermany Books Massive Foreign Direct Investment Increase in 2022
Berlin (ots) - The United States and post-Brexit Britain drove an unprecedented level of FDI in Germany in the past year. Even without a huge investment by chipmaker Intel, the value of business expansion was up considerably. Despite the economic turmoil following Russia’s war on Ukraine, 2022 was a record year for international business expansion to Germany. That’s the conclusion of the annual FDI Report by Germany ...
mehrDEBIOPHARM LAUNCHES PHASE 1/2 COMBINATION TRIAL INVESTIGATING BRAIN-PENETRANT SELECTIVE WEE1 INHIBITOR FOR BRAIN CANCER PATIENTS
Lausanne (ots) - - Glioblastomas (GBM) are among the most aggressive and lethal tumors of the central nervous system with a 5-year survival rate of only 6.8%. - Debiopharm is combining its potent, brain penetrant WEE1 inhibitor Debio 0123 with standard of care (SOC) therapy. Debio 0123 hopes to hinder DNA damage ...
mehrCroma-Pharma receives marketing authorisation for Letybo® in a further 12 European markets
Vienna (ots/PRNewswire) - Croma (Croma-Pharma® GmbH) announced today that it has received marketing authorisation for Letybo®, the company's botulinum toxin product, in 12 additional European markets. These include Belgium, Cyprus, Czech Republic, Denmark, Finland, Greece, Hungary, Luxembourg, Malta, Norway, Slovakia and Sweden. Letybo® will be launched in these ...
mehrBLOGPOST Writing a press release: Basics, Objectives, Buildup and Checklist
mehrHellmann achieves another record result in 2022
mehrTÜV Rheinland acquires part of ABB’s Energy Industries division
mehrPM: Deutschland hat das viertgünstigste Briefporto in Europa / PR: Germany has the fourth-lowest letter postage rate in Europe
2 DokumentemehrCIVIS Media Prize 2023 | 24 productions nominated, 4 podcasts for public voting
Cologne (ots) - CIVIS Media Prize 2023 – 24 nominees for Europe's most important media prize for integration and cultural diversity have been shortlisted. Candidates for the CIVIS Media Prize include, among others, entries from 3sat, ARTE, Deutschlandradio, The Europeans, Filmakademie Baden-Württemberg, University of Television and Film Munich, Kobalt Productions, ...
mehr- 3
PM: Großer Erfolg für die erste europäische Ausgabe des World Happiness Summit® (WOHASU®) / PR: Great success for the first European edition of the World Happiness Summit® (WOHASU®)
mehr beetz brothers film production
Ground-breaking prime documentary series by Emmy nominated gebrueder beetz filmproduktion – World premiere at Canneseries – JUAN CARLOS: Downfall of The King
mehr- 4
Six Materials Nominated for the Innovation Award “Renewable Material of the Year 2023”
2 Dokumentemehr DEBIOPHARM ANNOUNCES LAUNCH OF THE PHASE 1/2 GaLuCi™ STUDY FOR ITS CA IX-TARGETED RADIOPHARMACEUTICAL PROGRAM
Lausanne, Switzerland (ots/PRNewswire) - - Debiopharm is developing personalized radiotherapy through a theranostic approach, combining diagnostic imaging (Debio 0328 a gallium-labelled imaging tool) and therapeutic components (Debio 0228, a lutetium-labelled radioligand), thus allowing the pre-identification and ...
mehrDEBIOPHARM ANNOUNCES LAUNCH OF THE PHASE 1/2 GaLuCiTM STUDY FOR ITS CA IX-TARGETED RADIOPHARMACEUTICAL PROGRAM
Lausanne, Switzerland (ots) - - Debiopharm is developing personalized radiotherapy through a theranostic approach, combining diagnostic imaging (Debio 0328 a gallium-labelled imaging tool) and therapeutic components (Debio 0228, a lutetium-labelled radioligand), thus allowing the pre-identification and treatment of ...
mehrMiltenyi Biotec acquires biosensor company lino Biotech
Zurich (ots) - lino Biotech, a leading biosensor company and the world’s only provider of Focal Molography, announced today it has been acquired by Miltenyi Biotec, a global biotech company based in Germany, on February 22, 2023. Since its founding in 2020, lino Biotech has made significant advances in developing new biosensors to facilitate quality control in bioprocessing, measuring viral load in cell & gene therapy ...
mehrDFS Deutsche Flugsicherung GmbH
World’s first satellite-based precision landings under low visibility conditions receive ATM Award
Press Release 14 March 2023, Geneva, Switzerland / Langen, Germany World’s first satellite-based precision landings under low visibility conditions receive ATM Award The world’s first ground-based augmentation system (GBAS) for satellite-based precision landings with increased glideslope under low visibility ...
mehrAdapting to climate change challenging for four global vulnerable regions if 1.5°C limit crossed: report
mehr- 4
How AM is changing the manufacture and application of modern defence technology
Ein Dokumentmehr Press release: STADA sustains strong momentum with double-digit sales and profit growth in 2022
Ein DokumentmehrDEBIOPHARM EXTENDS THEIR DNA DAMAGE REPAIR FOOTPRINT WITH NEW ONCOLOGY PIPELINE ENTRY
Lausanne, Switzerland (ots) - Debiopharm obtains global rights from Novo Nordisk for the development of their ubiquitin-specific protease 1 (USP1) inhibitor Debiopharm (www.debiopharm.com), an independent Swiss-based, biopharmaceutical company aiming to develop tomorrow’s standard-of-care treatments to cure cancer and infectious diseases, today announced having ...
mehrMWC: Deutsche Telekom and European Space Agency strive for maximum resilience
Bonn / Barcelona, February 27th, 2023 MEDIAINFORMATION Deutsche Telekom and European Space Agency strive for maximum resilience - Joint initiative for more secure networks with borderless connectivity - Memorandum of understanding signed to improve integration of satellites - DT achieves worldwide first 5G-connection from stratosphere backhauled over Intelsat's ...
mehr